Eric J. Woodard

Dr. Eric Woodard received his medical degree from the Pennsylvania State University and completed his residency in Neurological surgery at Emory University. Following residency, Dr. Woodard completed a fellowship in complex spinal surgery at the Medical College of Wisconsin under Dr. Sanford Larsen. He is a diplomat of the American Board of Neurological Surgeons.

Dr. Woodard was formerly Chief of the Division of Spinal Surgery in the Department of Neurological Surgery at Brigham and Women’s Hospital, where he held the rank of Assistant Professor in Surgery at Harvard Medical School.

Since joining the medical staff in 2004, Dr. Woodard has continued to practice complex spinal surgery and has established the Neurosurgery Fellowship in spinal surgery at New England Baptist Hospital. He has been an editorial board member for The Journal of Spinal Disorders, Spine Universe.com and is an ad hoc reviewer for Neurosurgery, Journal of Neurosurgery and the New England Journal of Medicine.

Dr. Woodard is a member of numerous professional societies and organizations that include the American Association of Neurological Surgeons, the Congress of Neurological Surgeons, the Joint Section of the AANS/CNS, Spine and Peripheral Nerve, AO Spine North America, the North American Spine Society, Massachusetts Medical Society, and the Racchidian Society. He is the immediate past chairman of the AO Spine North America Board and serves on the Board of AO Spine International.

Dr. Woodard has published many articles and book chapters in the field of spine surgery and lectures extensively, both nationally and internationally. He lives in Boston with his wife and children.

Eric J. Woodard is the Scientific Advisory Board at InVivo Therapeutics, based in United States, North America. With a background in Biotechnology, Eric J. Woodard has a rich history of leadership and innovation.Eric J. Woodard studied unknown unknown at Penn State University. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.